ArticleFrontiers in oncology2026
Sinonasal metastasis as the initial presentation of renal clear cell carcinoma: a dual-center retrospective study and proposed diagnostic algorithm.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the clinical characteristics, diagnostic approaches, and treatment strategies for metastatic clear cell renal cell carcinoma (ccRCC) initially presenting with sinonasal involvement, thereby enhancing early recognition and optimal management. Method: We conducted a retrospective dual-center cohort study on five patients with ccRCC who presented with initial nasal symptoms. These patients were admitted to the otolaryngology departments of two regional medical centers between August 2011 and September 2024. All patients underwent endoscopic sinus surgery, and a detailed review of the patients' clinical presentations, imaging and histopathological findings, treatment regimens (endoscopic resection followed by adjuvant therapy), and oncologic outcomes. Result: All five patients were male, aged 55 to 71 years with a median age of 66 years. Primary symptoms included epistaxis (3/5), nasal obstruction (5/5), and decreased vision (1/5). The diagnosis was confirmed by preoperative biopsy in three cases and intraoperative pathological examination in the remaining two. Complete tumor resection was achieved via endoscopic nasal surgery. Over a follow-up ranging from 17 to 50 months, three patients were alive with no evidence of disease (ANED) at 40, 48 and 50 months, respectively; one patient with concurrent lung metastasis died at 17 months; and one patient was lost to follow-up at 36 months. The median follow-up was 38 months (range: 17-50). Conclusion: Our findings support the role of complete endoscopic resection combined with systemic therapy in oligometastatic ccRCC. The proposed diagnostic algorithm provides a structured pathway to mitigate diagnostic delay. Heightened clinical vigilance and the application of such a pathway are essential for early diagnosis and optimal management in patients presenting with unexplained sinonasal symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.